A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

COMPLETED

Centre Fran�ois Baclesse, Caen

COMPLETED

Columbia University Medical Center, New York

ACTIVE_NOT_RECRUITING

Memorial Sloan Kettering Cancer Center, New York

COMPLETED

Institut Paoli Calmettes, Marseille

COMPLETED

Hopitaux de La Timone, Marseille

COMPLETED

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

WITHDRAWN

Clinique Armoricaine de Radiologie-PPDS, Saint-Brieuc

COMPLETED

University of Virginia Comprehensive Cancer Center, Charlottesville

COMPLETED

Hospital General Universitario Gregorio Mara�on, Madrid

COMPLETED

Clinica Universidad de Navarra, Madrid

COMPLETED

Hospital Clinico San Carlos, Madrid

COMPLETED

Hospital Universitario Ramon y Cajal, Madrid

WITHDRAWN

Medical University of South Carolina, Charleston

COMPLETED

Winship Cancer Institute, Atlanta

ACTIVE_NOT_RECRUITING

Georgia Cancer Center, Augusta

COMPLETED

University of Miami, Coral Gables

ACTIVE_NOT_RECRUITING

Moffitt Cancer Center and Research Institute, Tampa

COMPLETED

Chattanooga's Program in Women's Oncology, Chattanooga

WITHDRAWN

Norton Healthcare, Louisville

WITHDRAWN

OSU Wxner Medical Center, Hilliard

COMPLETED

EDOG Institut de Cancerologie de l�Ouest, Nantes

WITHDRAWN

Clinique Catherine de Sienne, Nantes

COMPLETED

Hospital Universitario de Toledo, Toledo

COMPLETED

University of Cincinnati Medical Center, Cincinnati

COMPLETED

Fundacion Instituto Valenciano de Oncologia, Valencia

ACTIVE_NOT_RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

COMPLETED

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

COMPLETED

Karmanos Cancer Institute, Detroit

WITHDRAWN

Henry Ford Hospital, Detroit

COMPLETED

Centre Oscar Lambret, Lille

WITHDRAWN

Ascension Illinois-Skokie Infustion Center, Skokie

ACTIVE_NOT_RECRUITING

Northwestern Memorial Hospital, Chicago

COMPLETED

Centre Hospitalier de La C�te Basque, Bayonne

COMPLETED

ICANS - Institut de canc�rologie Strasbourg Europe, Strasbourg

COMPLETED

Centre L�on B�rard Centre R�gional de Lutte Contre Le Cancer Rh�ne Alpes, Lyone

COMPLETED

Universty of Arkansas for Medical Sciences, Little Rock

COMPLETED

H�pital de la Croix Saint-Simon, Paris

COMPLETED

Hopital Cochin, Paris

WITHDRAWN

The University of Texas MD Anderson Cancer Center, Houston

WITHDRAWN

ACRC/Arizona Clinical Research Center, Inc, Tucson

ACTIVE_NOT_RECRUITING

Stanford Women's Cancer Center, Palo Alto

COMPLETED

CLCC-Gustave Roussy Cancer, Vilejuif

WITHDRAWN

Oregon Health & Science University, Portland

COMPLETED

MD Anderson Cancer Center at Cooper, Camden

WITHDRAWN

Vanderbilt University Medical Center, Nashville

COMPLETED

Centre Antoine Lacassagne Centre R�gional de Lutte Contre Le Cancer, Nice

RECRUITING

National Cancer Center Hospital, Chūōku

RECRUITING

Cancer Institute Hospital of JFCR, Kōtoku

ACTIVE_NOT_RECRUITING

ICO Badalona-H.U. Germans Trias i Pujol, Badalona

ACTIVE_NOT_RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

WITHDRAWN

Belfast City Hospital, Belfast

COMPLETED

Beatson West of Scotland Cancer Centre-PPDS, Glasgow

COMPLETED

The Christie NHS Foundation Trust, Manchester

COMPLETED

Lancashire Clinical Research Facility, Royal Preston Hospital, Preston

COMPLETED

Guy's and St Thomas's Hospital, London

COMPLETED

Mount Vernon Cancer Centre, Northwood

COMPLETED

Velindre Cancer Centre-PPDS, Cardiff

WITHDRAWN

The Royal Marsden in Sutton, Sutton